Severe Optic Neuropathy Induced by Very Prolonged Tedizolid as Suppressive Therapy: Description of a Case Report and Implication for Better Assessment

Severe Optic Neuropathy Induced by Very Prolonged Tedizolid as Suppressive Therapy: Description of a Case Report and Implication for Better Assessment

Abstract The long-term tolerability of linezolid is low because of mitochondrial toxicity, whereas tedizolid may represent a better option for suppressive therapy. We report a first presumed case of tedizolid-associated optic neuropathy after a very prolonged (18-month) intake and believe that scree...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Open Forum Infectious Diseases 2024-09, Vol.11 (9), p.ofae517
Hauptverfasser: Coustilleres, F, Thillard, E M, Khanna, R K, Olivereau, S, Ouaissi, M, Pansu, N, Le Lez, M L
Format: Artikel
Sprache:eng
Schlagworte:
Antibacterial agents
Caspofungin
Clopidogrel
Complications and side effects
Infection
Methicillin
Novel ID Cases
Protein biosynthesis
Transplantation of organs, tissues, etc
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract The long-term tolerability of linezolid is low because of mitochondrial toxicity, whereas tedizolid may represent a better option for suppressive therapy. We report a first presumed case of tedizolid-associated optic neuropathy after a very prolonged (18-month) intake and believe that screening for optic neuropathy should be considered for patients undergoing tedizolid suppression.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofae517